. Author manuscript; available in PMC: 2022 Nov 1.

Published in final edited form as: Head Neck. 2021 Jul 16;43(11):3331–3344. doi: 10.1002/hed.26820

Table 3.

Cumulative Acute and Late Toxicities, Feeding Tube Requirement

	All Patients (n=137)	Mucosa SBRT Site (n=55)	Non-Mucosa SBRT Site (n=82)	p-value	Concurrent Chemotherapy (n=96)	No Concurrent Chemotherapy (n=41)	p-value
Any Grade 2+ Toxicity	42 (31%)	27 (49%)	15 (18%)	0.001	36 (38%)	6 (15%)	0.01
Any Grade 3+ Toxicity	21 (15%)	16 (29%)	5 (6%)	0.001	19 (20%)	2 (5%)	0.02
Feeding Tube Required^a	22 (21%)	17 (38%)	5 (8%)	<0.001	18 (25%)	4 (11%)	0.07

Excludes n=23 patients who had feeding tube placed prior to SBRT and n=7 patients who had feeding tube placed for other confirmed cause (i.e. surgery, frank tumor progression)

Abbreviations: SBRT, stereotactic body radiotherapy